Gene expression signature predictive of rapid response to imatinib mesylate in Gastrointestinal Stromal Tumor (GIST)

ABSTRACT: Gene expression profiling using oligonucleotide microarrays performed on tumor samples obtained before and after imatinib mesylate (IM) therapy. Rapid responding (to IM) samples were compared to non-responding/stable disease samples as measured by CT scan measurements to identify a gene signature that can predict rapid response to IM.

ORGANISM(S): Homo sapiens

PROVIDER: GSE15966 | GEO | 2009/11/24

SECONDARY ACCESSION(S): PRJNA115541

REPOSITORIES: GEO